+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Custom Antibody Market by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), Service (Antibody Development, Antibody Fragmentation & Labeling, Antibody Production & Purification), Source, Research Area, End Users, Application - Forecast 2024-2030- Product Image
Global Custom Antibody Market by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), Service (Antibody Development, Antibody Fragmentation & Labeling, Antibody Production & Purification), Source, Research Area, End Users, Application - Forecast 2024-2030- Product Image
Sale

Global Custom Antibody Market by Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), Service (Antibody Development, Antibody Fragmentation & Labeling, Antibody Production & Purification), Source, Research Area, End Users, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674843
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Custom Antibody Market size was estimated at USD 407.63 million in 2023, USD 478.23 million in 2024, and is expected to grow at a CAGR of 20.42% to reach USD 1,497.58 million by 2030.

Custom antibodies are specifically designed and produced to target a particular antigen and are custom-made and tailored to a specific requirement, such as binding to a particular protein region or recognizing a special post-translational modification. The custom antibody market has experienced growth in recent years due to factors such as an increase in R&D activities and a rise in funding from the government to carry out the research. In addition, the increase in therapeutics of antibodies, expansion of drug pipeline, and rise in collaborations of industry and academic institutions for research are significantly driving the market's growth. Surging demand for protein therapeutics and the production of custom antibodies are adding to the driving force for market growth. However, high expenses in process and the time required for production are restricting the market growth for the last few years. Nevertheless, developments in research infrastructure enable emerging countries to continue to support custom antibody startups and SMEs, strengthen the emerging bioeconomy, and help unlock the societal benefits of custom antibody.

Regional Insights

Increasing demand for customized diagnostics and treatments has encouraged players from the U.S., the UK, Germany, China, and India to invest in product development and expansion strategies, accelerating the market growth across North America, Europe, and Asia-Pacific regions. North America has been witnessed to hold a significant market share, owing to the presence of leading companies, extensive government funding, and increased research activities in the region. Additionally, large-scale cancer & genomics research programs have been conducted by universities in the U.S. and Canada that have accelerated the progress in the biotechnology sector, thereby increasing the demand for high-throughput technology solutions in laboratory workflows. North America is expected to grow over the forecast period owing to the rapid adoption of advanced technological solutions, high investments in R&D, and rising wages of skilled personnel. The markets in Europe and the Asia-Pacific are estimated to grow rapidly, which can be attributed to the increasing interest of key global players in capturing regional revenue share by expanding into emerging markets. Global investors are increasingly investing in China, Germany, and India due to economic developments. Regional players are also strengthening their presence in the global custom antibodies market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Custom Antibody Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Custom Antibody Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Custom Antibody Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, ABclonal, Inc., Abgenex Pvt. Ltd., Abimate Pharmaceutical (Shanghai) Co., Ltd., Abnova Corporation, Acrobiosystems Inc., Agilent Technologies, Inc., Alta Bioscience Limited, Bio Basic Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioChain Incorporated, Bioklone Biotech Private Limited, BioLegend, Inc. by PerkinElmer, Inc., Biosynth Ltd., Boster Biological Technology, BTL Biotechno Labs Private Limited, Capralogics, Inc., Cell Signaling Technology, Inc., CiteAb Limited, Creative Biolabs, Creative Diagnostics, CSBio (Shanghai) Ltd., Cusabio Technology LLC, Davids Biotechnologie GmbH, Elabscience, evitria AG, GenScript Biotech Corporation, Imgenex India Pvt. Ltd., Innovagen AB, Inotiv, Inc., Kaneka Eurogentec S.A., Laboratory Corporation of America Holdings, Merck KGaA, Metabion International AG, MyBiosource, Inc., OriGene Technologies, Inc., Oy Medix Biochemica AB, Pacific Immunology, PhosphoSolutions, ProMab Biotechnologies, Inc., ProSci Incorporated, ProteoGenix SA, RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Sino Biological, Inc., The Antibody Company, Thermo Fisher Scientific, Inc., and YenZym Antibodies, LLC.

Market Segmentation & Coverage

This research report categorizes the Custom Antibody Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies
  • Service
    • Antibody Development
    • Antibody Fragmentation & Labeling
    • Antibody Production & Purification
  • Source
    • Mice
    • Rabbit
  • Research Area
    • Cardiovascular Diseases
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Stem cells
  • End Users
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
  • Application
    • Research
    • Therapeutics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Custom Antibody Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Custom Antibody Market?
  3. What are the technology trends and regulatory frameworks in the Custom Antibody Market?
  4. What is the market share of the leading vendors in the Custom Antibody Market?
  5. Which modes and strategic moves are suitable for entering the Custom Antibody Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Custom Antibody Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic infectious disease across the globe
5.1.1.2. Expanding applications of custom antibody across research, diagnostics, and therapeutics
5.1.1.3. Soaring R&D activities and increasing awareness on personalized therapeutics
5.1.2. Restraints
5.1.2.1. Requirements of huge time and extensive capital to develop custom antibodies
5.1.3. Opportunities
5.1.3.1. Ongoing strategic investments in life science and biology sector by governments and private sectors
5.1.3.2. Increase in therapeutics of antibodies and expansion of drug pipeline
5.1.4. Challenges
5.1.4.1. Presence of alternative antibodies create fragmentation in the market
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Custom Antibody Market, by Type
6.1. Introduction
6.2. Monoclonal Antibodies
6.3. Polyclonal Antibodies
6.4. Recombinant Antibodies
7. Custom Antibody Market, by Service
7.1. Introduction
7.2. Antibody Development
7.3. Antibody Fragmentation & Labeling
7.4. Antibody Production & Purification
8. Custom Antibody Market, by Source
8.1. Introduction
8.2. Mice
8.3. Rabbit
9. Custom Antibody Market, by Research Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Immunology
9.4. Infectious Diseases
9.5. Neurobiology
9.6. Oncology
9.7. Stem cells
10. Custom Antibody Market, by End Users
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotechnology Companies
11. Custom Antibody Market, by Application
11.1. Introduction
11.2. Research
11.3. Therapeutics
12. Americas Custom Antibody Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Custom Antibody Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Custom Antibody Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
15.3.1. Merger & Acquisition
15.3.1.1. LSBio Acquires Absolute Antibody Ltd.
15.3.1.2. AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline
15.3.1.3. KKR-backed Biosynth Carbosynth Acquires vivitide and Welcomes Ampersand Capital Partners as New Shareholder
15.3.2. Agreement, Collaboration, & Partnership
15.3.2.1. Specifica Announces Antibody Discovery Platform Transfer Agreement with Servier and its Subsidiary Symphogen
15.3.2.2. Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies
15.3.2.3. AltaBioscience partners with Life Science Group for custom antibody production services
15.3.2.4. Sino Biological and Ainnocence partner to offer next-generation antibody development CRO services
15.3.2.5. Ligand signs merger agreement with Avista Public Acquisition
15.3.3. New Product Launch & Enhancement
15.3.3.1. Absolute Biotech launches to offer worldwide antibody solutions
15.3.3.2. Sanofi and Seagen announce collaboration to develop and commercialize multiple novel antibody-drug conjugates
15.3.4. Award, Recognition, & Expansion
15.3.4.1. Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. Abbiotec, Inc.
16.1.2. Abcam PLC
16.1.3. ABclonal, Inc.
16.1.4. Abgenex Pvt. Ltd.
16.1.5. Abimate Pharmaceutical (Shanghai) Co., Ltd.
16.1.6. Abnova Corporation
16.1.7. Acrobiosystems Inc.
16.1.8. Agilent Technologies, Inc.
16.1.9. Alta Bioscience Limited
16.1.10. Bio Basic Inc.
16.1.11. Bio-Rad Laboratories, Inc.
16.1.12. Bio-Techne Corporation
16.1.13. BioChain Incorporated
16.1.14. Bioklone Biotech Private Limited
16.1.15. BioLegend, Inc. by PerkinElmer, Inc.
16.1.16. Biosynth Ltd.
16.1.17. Boster Biological Technology
16.1.18. BTL Biotechno Labs Private Limited
16.1.19. Capralogics, Inc.
16.1.20. Cell Signaling Technology, Inc.
16.1.21. CiteAb Limited
16.1.22. Creative Biolabs
16.1.23. Creative Diagnostics
16.1.24. CSBio (Shanghai) Ltd.
16.1.25. Cusabio Technology LLC
16.1.26. Davids Biotechnologie GmbH
16.1.27. Elabscience
16.1.28. evitria AG
16.1.29. GenScript Biotech Corporation
16.1.30. Imgenex India Pvt. Ltd.
16.1.31. Innovagen AB
16.1.32. Inotiv, Inc.
16.1.33. Kaneka Eurogentec S.A.
16.1.34. Laboratory Corporation of America Holdings
16.1.35. Merck KGaA
16.1.36. Metabion International AG
16.1.37. MyBiosource, Inc.
16.1.38. OriGene Technologies, Inc.
16.1.39. Oy Medix Biochemica AB
16.1.40. Pacific Immunology
16.1.41. PhosphoSolutions
16.1.42. ProMab Biotechnologies, Inc.
16.1.43. ProSci Incorporated
16.1.44. ProteoGenix SA
16.1.45. RayBiotech Life, Inc.
16.1.46. Rockland Immunochemicals, Inc.
16.1.47. Sino Biological, Inc.
16.1.48. The Antibody Company
16.1.49. Thermo Fisher Scientific, Inc.
16.1.50. YenZym Antibodies, LLC
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. CUSTOM ANTIBODY MARKET RESEARCH PROCESS
FIGURE 2. CUSTOM ANTIBODY MARKET SIZE, 2023 VS 2030
FIGURE 3. CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CUSTOM ANTIBODY MARKET DYNAMICS
FIGURE 7. CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
FIGURE 10. CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 12. CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2030 (%)
FIGURE 14. CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 16. CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 18. CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 28. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CUSTOM ANTIBODY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CUSTOM ANTIBODY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CUSTOM ANTIBODY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. CUSTOM ANTIBODY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CUSTOM ANTIBODY MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CUSTOM ANTIBODY MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 10. CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY FRAGMENTATION & LABELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CUSTOM ANTIBODY MARKET SIZE, BY ANTIBODY PRODUCTION & PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 14. CUSTOM ANTIBODY MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CUSTOM ANTIBODY MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 17. CUSTOM ANTIBODY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CUSTOM ANTIBODY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CUSTOM ANTIBODY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CUSTOM ANTIBODY MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CUSTOM ANTIBODY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CUSTOM ANTIBODY MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 24. CUSTOM ANTIBODY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. CUSTOM ANTIBODY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. CUSTOM ANTIBODY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. CUSTOM ANTIBODY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. CUSTOM ANTIBODY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 52. CANADA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 53. CANADA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 54. CANADA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 55. CANADA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CUSTOM ANTIBODY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. CHINA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 84. CHINA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 85. CHINA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 86. CHINA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 87. CHINA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. INDIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 90. INDIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 91. INDIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 92. INDIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 93. INDIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 102. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 103. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 104. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 105. JAPAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 138. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 139. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 140. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CUSTOM ANTIBODY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 158. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 159. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 160. DENMARK CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 165. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 169. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 171. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 177. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 181. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 183. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ITALY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. ITALY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 193. ITALY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 194. ITALY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 195. ITALY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 196. ITALY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 211. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 213. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. POLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. POLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 217. POLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 218. POLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 219. POLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 220. POLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. QATAR CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. QATAR CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 223. QATAR CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 224. QATAR CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 225. QATAR CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 226. QATAR CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 247. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 249. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 265. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 266. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 267. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY RESEARCH AREA, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM CUSTOM ANTIBODY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. CUSTOM ANTIBODY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 282. CUSTOM ANTIBODY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 283. CUSTOM ANTIBODY MARKET LICENSE & PRICING

Companies Mentioned

  • Abbiotec, Inc.
  • Abcam PLC
  • ABclonal, Inc.
  • Abgenex Pvt. Ltd.
  • Abimate Pharmaceutical (Shanghai) Co., Ltd.
  • Abnova Corporation
  • Acrobiosystems Inc.
  • Agilent Technologies, Inc.
  • Alta Bioscience Limited
  • Bio Basic Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioChain Incorporated
  • Bioklone Biotech Private Limited
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Biosynth Ltd.
  • Boster Biological Technology
  • BTL Biotechno Labs Private Limited
  • Capralogics, Inc.
  • Cell Signaling Technology, Inc.
  • CiteAb Limited
  • Creative Biolabs
  • Creative Diagnostics
  • CSBio (Shanghai) Ltd.
  • Cusabio Technology LLC
  • Davids Biotechnologie GmbH
  • Elabscience
  • evitria AG
  • GenScript Biotech Corporation
  • Imgenex India Pvt. Ltd.
  • Innovagen AB
  • Inotiv, Inc.
  • Kaneka Eurogentec S.A.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Metabion International AG
  • MyBiosource, Inc.
  • OriGene Technologies, Inc.
  • Oy Medix Biochemica AB
  • Pacific Immunology
  • PhosphoSolutions
  • ProMab Biotechnologies, Inc.
  • ProSci Incorporated
  • ProteoGenix SA
  • RayBiotech Life, Inc.
  • Rockland Immunochemicals, Inc.
  • Sino Biological, Inc.
  • The Antibody Company
  • Thermo Fisher Scientific, Inc.
  • YenZym Antibodies, LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 478.23 Million
Forecasted Market Value ( USD ) by 2030 $ 1497.58 Million
Compound Annual Growth Rate20.4%
Regions CoveredGlobal
No. of Companies Mentioned50

Related Topics

Related Reports

Custom Antibody - Global Strategic Business Report - Product Image

Custom Antibody - Global Strategic Business Report

  • Report
  • 127 Pages
  • Global
From
Global Custom Antibody Market Report and Forecast 2024-2032 - Product Image

Global Custom Antibody Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Global Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Forecast 2023-2030 - Product Image

Global Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Forecast 2023-2030

  • Report
  • 190 Pages
  • Global
From
2024 Global Forecast for Custom Antibody Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Custom Antibody Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Non-Therapeutic Biomolecules Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Non-Therapeutic Biomolecules Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 182 Pages
  • Global
From

About the Custom Antibody Market

The Custom Antibody market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic proteins and antibodies. Custom Antibodies are antibodies that are designed and produced to specifically target a particular antigen. They are used in a variety of applications, such as diagnostics, drug discovery, and therapeutic treatments. Custom Antibodies are produced through a variety of methods, including hybridoma technology, phage display, and recombinant DNA technology. Custom Antibodies are used in a variety of research and clinical applications, including immunoassays, immunohistochemistry, flow cytometry, and ELISA. They are also used in drug discovery and development, as well as in the development of therapeutic treatments. Some companies in the Custom Antibody market include Abcam, Bio-Rad, Merck Millipore, Thermo Fisher Scientific, and GenScript. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.